ArticleIranian journal of basic medical sciences2021
Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cells.
SeyedAli Alambeladi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.